Modified models to distinguish central nervous system demyelinating diseases with brain lesions.

Mult Scler Relat Disord

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address:

Published: July 2021

Background: Brain lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are indistinguishable from those with relapsing-remitting multiple sclerosis (RRMS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-Ab NMOSD).

Methods: Patients with MOGAD, RRMS, and AQP4-Ab NMOSD with abnormal brain lesions were retrospectively reviewed and divided into training and validation sets. Discriminatory models using brain images and demographics were generated to identify optimal predictors using orthogonal partial least square discriminant analysis after principal component analysis (PCA) of clinico-radiological data without a diagnosis. Constructed models were tested in an independent cohort.

Results: PCA of 51 brain scans and demographics from patients (13 MOGAD, 24 RRMS, and 14 AQP4-Ab NMOSD) demonstrated that RRMS was distinct from antibody-mediated conditions. The best predictors between MOGAD and AQP4-Ab NMOSD were poorly demarcated lesions, large abnormalities (both predictive for MOGAD), female sex, disease duration, linear lesions adjacent to the lateral ventricle, and cerebellum involvement (all predictive for MOGAD). Periventricular, ovoid/round, juxtacortical, and callosal lesions; Dawson's fingers; T1 hypointensity (all predictive for RRMS); and fluffy as well as large lesions (for MOGAD) were the best predictors of MOGAD and RRMS. RRMS versus MOGAD and RRMS versus AQP4-Ab NMOSD models exhibited a high predictive value and perfect accuracy (100%), which was validated in an independent cohort. The model of patients with AQP4-Ab NMOSD and MOGAD exhibited lower predictive power but still achieved an accuracy of 90%.

Conclusions: Brain MRI characteristics combined with demographics enables the distinction of MOGAD from RRMS and AQP4-Ab NMOSD. Fluffy and large lesions are relatively specific MRI characteristics in patients with MOGAD with brain abnormalities in Asian countries.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2021.102965DOI Listing

Publication Analysis

Top Keywords

aqp4-ab nmosd
24
mogad rrms
20
brain lesions
12
mogad
12
patients mogad
12
rrms aqp4-ab
12
rrms
9
lesions
8
best predictors
8
predictors mogad
8

Similar Publications

Background: The impact of early intervention with immunosuppressive treatment (IST) in anti-Aquaporin4-antibody (AQP4-ab) seropositive neuromyelitis optica spectrum disorder (NMOSD) has not been thoroughly evaluated.

Objective: This study aims to assess the effects of early IST intervention in patients with NMOSD.

Methods: This retrospective cohort study included 174 treatments from 137 NMOSD patients seropositive for AQP4-antibody, treated with ISTs such as rituximab, mycophenolate mofetil, azathioprine, or tacrolimus.

View Article and Find Full Text PDF

Preceding hepatitis B virus infection is highly prevalent in patients with neuromyelitis optica spectrum disorder in Taiwan.

Mult Scler Relat Disord

December 2024

Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. Electronic address:

Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system, characterized by pathogenic anti-Aquaporin-4 antibodies (AQP4-Ab). Given that infections can trigger autoimmune responses, we investigated the association between Hepatitis B virus (HBV) infection and NMOSD.

Methods: HBV and hepatitis C virus serologies were analyzed in 105 NMOSD patients, 85 multiple sclerosis (MS) patients, and 1,661 healthy Taiwanese controls.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied the quality of life (QOL) of patients with a condition called MOGAD and compared it to another condition called AQP4-IgG positive NMOSD.
  • They found that the overall QOL was similar between both groups, but many patients in both groups struggled with sleep, pain, and feelings of sadness.
  • The study suggests that both conditions need more focus on improving sleep and mental health to help patients feel better overall.
View Article and Find Full Text PDF

Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders.

J Neurol Sci

November 2024

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Neuroscience Center, Samsung Medical Center, Seoul, Republic of Korea. Electronic address:

Article Synopsis
  • Neuromyelitis optica spectrum disorder (NMOSD) is a central nervous system disease that differs from multiple sclerosis by the presence of anti-aquaporin 4 antibodies (AQP4-ab) and occasionally other non-organ-specific autoantibodies.
  • A study involving 158 NMOSD patients collected data on various autoantibodies and analyzed their impact on clinical characteristics and disability levels.
  • Results indicated that the rheumatoid factor (RF) was significantly associated with higher disability levels; RF, age at onset, and annual relapse rate (ARR) emerged as key predictors for severe disability in NMOSD patients.
View Article and Find Full Text PDF
Article Synopsis
  • Symmetrical lesions in the temporal poles and external capsules on brain MRI are typically linked to CADASIL but can also appear in NMOSD.
  • A study with 55 NMOSD patients revealed that 33 had brain lesions, with only 2 (6%) showing the specific symmetrical lesions linked to CADASIL.
  • The findings suggest that when such lesions appear on MRI, NMOSD should be included in the list of possible diagnoses.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!